The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: A unique profile of both independent and founder events

American Journal of Human Genetics

Volumn 65, Issue 5, 1999, Pages 1308-1320

  Moolman Smook, Johanna C ^a   De Lange, Willem J ^a   Bruwer, Eduard C D ^a   Brink, Paul A ^b   Corfield, Valerie A ^a  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN HEAVY CHAIN;

AMINO ACID SUBSTITUTION; ARTICLE; CHROMOSOME 14Q; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOUNDER EFFECT; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PEDIGREE; PRIORITY JOURNAL; SOUTH AFRICA;

EID: 0033361790     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302623     Document Type: Article

References (36)

1. Al-Mahdawi S, Chamberlain S, Chojmowska L, Machalak E, Nihoyannopoulos P, Ryan M, Kusnierczyk B, et al (1994) The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene. Br Heart J 72: 105-111
2. Bonne G, Carrier L, Richard P, Hainque B, Schwartz K (1998) Familial hypertrophic cardiomyopathy from mutations to functional defects. Circ Res 83:580-593
3. Botha MC, Beighton P (1983) Inherited disorders in the Afrikaner population of southern Africa. I. Historical and demographic background, cardiovascular, neurological, metabolic and intestinal conditions. S Afr Med J 64:609-612
4. Botha MC, Pritchard J (1972) Blood group frequencies: an indication of the genetic constitution of population samples in Cape Town. S Afr Med J Suppl 46:1-27
5. Brink PA, Ferreira A, Moolman JC, Weymar HW, Van der Merwe P-L, Corfield VA (1995) Gene for progressive familial heart block type I maps to chromosome 19q13. Circulation 91:1633-1640
6. Cameron T, Spies T (1992) Nuwe geskiedenis van Suid-Afrika, rev ed. Human & Rousseau, Cape Town
7. Carrier L, Bonne G, Bährend E, Yu B, Richard P, Niel F, Hainque B, et al (1997) Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res 80: 427-434
8. Consevage MW, Salada GC, Baylen BG, Ladda RL, Rogan PK (1994) A new missense mutation, Arg719Gln, in the β-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy. Hum Mol Genet 3:1025-1026
9. Corfield VA, Moolman JC, Martel R, Brink PA (1993) Polymerase chain reaction-based detection of MN blood group-specific sequences in the human genome. Transfusion 33: 119-124
10. Dausse E, Komajda M, Fetler L, Dubourg O, Dufour C, Carrier L, Wisnewsky C, et al (1993) Familial hypertrophic cardiomyopathy: rnicrosatellite haplotyping and identification of a hot spot for mutations in the β-myosin heavy chain gene. J Clin Invest 92:2807-2813
11. De Jager T, Corbett CH, Badenhorst JCW, Brink PA, Corfield VA (1996) Evidence of a long QT founder gene with varying phenotypic expression in South African families. J Med Genet 33:567-573
12. de la Chapelle A (1993) Disease gene mapping in isolated human populations: the example of Finland. J Med Genet 30:857-865
13. Feigenbaum H (1981) Echocardiography, 3d ed. Lea-Febigery, Philadelphia
14. Freiburg A, Gautel M (1996) A molecular map of the interactions of titin and myosin-binding protein C: implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur J Biochem 235:317-323
15. Gautel M, Zuffardi O, Freiburg A, Labeit S (1995) Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction? EMBO J 14:1952-1960
16. Jääskeläinen P, Soranta M, Miettinen R, Saarinen L, Pihlajamäki J, Silvennoinen K, Tikanoja T, et al (1998) The cardiac β-myosin heavy chain is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population, J Am Coll Cardiol 32:1709-1716
17. Jaenicke T, Diederich KW, Haas W, Schleich J, Lichter P, Pfordt M, Bach A, et al (1990) The complete sequence of human heta-myosin heavy chain gene and a comparative analysis of its product. Genomics 8:194-206
18. Kotze MJ, Langenhoven E, Warnich L, Du Plessis L, Retief AE (1991) The molecular basis and diagnosis of familial hypercholesterolaemia in South African Afrikaners. Ann Hum Genet 55:115-121
19. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation 92:785-789
20. May RM, Du Toit ED (1989) Blood group gene frequencies of four population groups in the western Cape. S Afr Med J 76:647-650
21. Mogensen J, Klausen IC, Pedersen AK, Egeblad H, Bross P, Kruse TA, Gregersen N, et al (1999) Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest 103:R39-43
22. Moolman JC, Brink PA, Corfield VA (1993) Identification of a new missense mutation at Arg403, a CpG mutation hotspot in exon 13 of the β-myosin heavy chain gene in hypertrophic cardiomyopathy. Hum Mol Genet 2:1731-1732
23. -(1995) Identification of a novel Ala797Thr mutation in exon 21 of MYH7. Hum Mutat 6:197-198
24. Moolman JC, Corfield VA, Posen B, Ngumbela K, Seidman C, Brink PA, Watkins H (1997) Sudden death due to troponin T mutations. J Am Coll Cardiol 29:549-555
25. Moolman-Smook JC, Mayosi B, Brink P, Corfield VA (1998) Identification of a new missense mutation in MyBP-C associated with hypertrophic cardiomyopathy. J Med Genet 35:253-254
26. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, Kristinsson A, et al (1998) Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 338:1248-1257
27. Posen BM, Moolman JC, Corfield VA, Brink PA (1995) Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac β myosin heavy chain gene mutations. Br Heart J 74:40-46
28. Rayment I, Holden HM, Sellers JR, Fananapazir L, Epstein ND (1995) Structural interpretation of the mutations in the β-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 92: 3864-3868
29. Teare RD (1958) Asymmetrical hypertrophy of the heart in young adults. Br Heart J 20:1-8
30. Theal GMcC (1922) History of South Africa. Vol 3. Struik, Cape Town
31. Thierfelder L, Watkins H, Macrae C, Lamas R, McKenna W, Vosberg H-P, Seidman JG, et al (1994) α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77: 701-712
32. Vikstrom KL, Leinwand LA (1996) Contractile protein mutations and heart disease. Curr Opin Cell Biol 8:97-105
33. Warnich L, Kotze MJ, Groenewald IM, Groenewald JZ, Van Brakel MG, Van Heerden CJ, De Villiers NP, et al (1996) Identification of three mutations and associated haplotypes in the protoporphyrinogen oxidase gene in South African families with variegate porphyria. Hum Mol Genet 5:981-984
34. Watkins H, MacRae C, Thierfelder L, Chou YH, Frenneaux M, McKenna W, Seidman JG, et al (1993a) A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3. Nat Genet 3:333-337
35. Watkins H, Rosenzweig T, Hwang D-S, Levi T, McKenna W, Seidman CE, Seidman JG (1992) Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 326: 1108-1114
36. Watkins H, Thierfelder L, Anan R, Jarcho J, Matsumori A, McKenna W, Seidman JG, et al (1993b) Independent origin of identical β cardiac myosin heavy-chain mutations in hypertrophic cardiomyopathy. Am J Hum Genet 53: 1180-1185